159 related articles for article (PubMed ID: 21965721)
21. P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region.
Gröbe A; Hanken H; Al-Dam A; Cachovan G; Smeets R; Krohn A; Clauditz T; Grob T; Simon R; Sauter G; Kluwe L; Heiland M; Blessmann M
Clin Oral Investig; 2014 Jan; 18(1):211-7. PubMed ID: 23404560
[TBL] [Abstract][Full Text] [Related]
22. p53 and cyclin A protein expression in squamous carcinoma of the oesophagus.
Chetty R; Simelane S
Pathol Oncol Res; 1999; 5(3):193-6. PubMed ID: 10491016
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical over expression of p53 in head and neck Squamous cell carcinoma: clinical and prognostic significance.
Hashmi AA; Hussain ZF; Hashmi SK; Irfan M; Khan EY; Faridi N; Khan A; Edhi MM
BMC Res Notes; 2018 Jul; 11(1):433. PubMed ID: 29970180
[TBL] [Abstract][Full Text] [Related]
24. TRAF4 is potently induced by TAp63 isoforms and localised according to differentiation in SCCHN.
Gu X; Coates PJ; MacCallum SF; Boldrup L; Sjöström B; Nylander K
Cancer Biol Ther; 2007 Dec; 6(12):1986-90. PubMed ID: 18087216
[TBL] [Abstract][Full Text] [Related]
25. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression.
van Oijen MG; Tilanus MG; Medema RH; Slootweg PJ
J Oral Pathol Med; 1998 Sep; 27(8):367-75. PubMed ID: 9736425
[TBL] [Abstract][Full Text] [Related]
26. Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
Owusu-Afriyie O; Owiredu WKBA; Owusu-Danquah K; Komarck C; Foltin SK; Larsen-Reindorf R; Acheampong E; Quayson SE; Prince MEP; McHugh JB; Donkor P; Merajver SD; Brenner JC
PLoS One; 2018; 13(8):e0202790. PubMed ID: 30138436
[TBL] [Abstract][Full Text] [Related]
27. Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region.
Wu M; Putti TC; Bhuiya TA
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):351-6. PubMed ID: 12607604
[TBL] [Abstract][Full Text] [Related]
28. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
29. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
[TBL] [Abstract][Full Text] [Related]
31. [No association between p53 overexpression and polarographically measured tumor oxygenation in patients with head and neck carcinomas].
Becker A; Stadler P; Krause U; Kuhnt T; Hänsgen G; Dettmar P; Feldmann HJ; Rath FW; Molls M; Dunst J
Strahlenther Onkol; 2000 Oct; 176(10):475-80. PubMed ID: 11068594
[TBL] [Abstract][Full Text] [Related]
32. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Frank DK; Liu TJ; Frederick MJ; Clayman GL
Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
[TBL] [Abstract][Full Text] [Related]
33. The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma.
Boslooper K; Lam AK; Gao J; Weinstein S; Johnson N
Pathology; 2008 Aug; 40(5):500-4. PubMed ID: 18604737
[TBL] [Abstract][Full Text] [Related]
34. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
35. Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Stangl S; Tontcheva N; Sievert W; Shevtsov M; Niu M; Schmid TE; Pigorsch S; Combs SE; Haller B; Balermpas P; Rödel F; Rödel C; Fokas E; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Stuschke M; Grosu AL; Abdollahi A; Debus J; Belka C; Maihöfer C; Mönnich D; Zips D; Multhoff G
Int J Cancer; 2018 May; 142(9):1911-1925. PubMed ID: 29235112
[TBL] [Abstract][Full Text] [Related]
36. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
37. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
[TBL] [Abstract][Full Text] [Related]
38. Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients.
Dijkema IM; Struikmans H; Dullens HF; Kal HB; van der Tweel I; Battermann JJ
Oral Oncol; 2000 Jan; 36(1):54-60. PubMed ID: 10889920
[TBL] [Abstract][Full Text] [Related]
39. Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.
Yildirim M; Müller von der Grün J; Winkelmann R; Fokas E; Rödel F; Ackermann H; Rödel C; Balermpas P
Strahlenther Onkol; 2017 Apr; 193(4):305-314. PubMed ID: 28144684
[TBL] [Abstract][Full Text] [Related]
40. [Expression and significance of phosphated signal transducer and activator of transcription 3 and p53 protein in laryngeal squamous cell carcinoma].
Dai L; Liu T; Zhou X; Wei Q; Li Y; Cui C; Li M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Sep; 27(18):991-4. PubMed ID: 24459924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
